Researchers explored data from more than 1,300 COVID-19 patients, sharing their findings in JAMA Internal Medicine. 

Overall, researchers found, women were less likely to undergo coronary angiography, percutaneous coronary intervention and mechanical circulatory support than men.

Patients who received TAVR and PCI experienced lower rates of mortality and fewer major bleeding events than those treated with SAVR and CABG. 

The analysis, written by representatives of the American Heart Association, focused on SGLT2 inhibitors and GLP-1 receptor agonists.

Researchers developed and implemented a four-step process for identifying patients who can be discharged early following PCI. 

The study's authors identified dozens of potential new biomarkers, sharing their findings in the Proceedings of the National Academy of Sciences.

Cardiology leaders share the innovations at the top of their wish lists.

Scott Atlas, MD, recently made the news after nearly 100 former Stanford colleagues questioned his views around the pandemic.